Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

Slides:

Advertisements

Similar presentations

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. Benefit of Anticoagulation Unlikely in Patients With Atrial.

Advertisements

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist.

Tell-tale Telangiectasias

Colloquium on Therapy of Right Heart Failure

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.

Volume 70, Issue 1, Pages (July 2017)

Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke

Volume 146, Issue 5, Pages (November 2014)

When to Be Rash About a Fever and Headache

Right-Sided Chest Pain with Progressive Dyspnea

Volume 56, Issue 1, Pages (July 1969)

National Guidelines for Nursing Delegation

Bovine Tuberculosis Eradication

Volume 29, Issue 3, Pages (June 2013)

Hyperbaric Oxygenation in Cardiac and Pulmonary Disease

Air Pollution and Chest Disease

Rheumatic Heart Disease in East Pakistan

Prevalence of Sleep Apnea Syndrome in Lone Atrial Fibrillation

Frontiers of anticoagulation therapy for atrial fibrillation

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines Laurent Macle, MD,

Frank W. Ewald, MD, FCCP, Albert H. Scherff, MD CHEST

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal Gregory.

Volume 14, Issue 6, Pages (June 2017)

Role of the CHADS2 Score in Acute Coronary Syndromes

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

CHADS2 Score Predicts Postoperative Atrial Fibrillation in Patients Undergoing Elective Pulmonary Lobectomy Svetlana Kotova, MD, Mansen Wang, PhD, Katie.

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Laurent Macle, MD, John Cairns, MD, Kori.

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control

Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation Lena Rivard, MD, MSc, Paul Khairy, MD,

Volume 137, Issue 2, Pages (February 2010)

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

Managing Patients With Transient Ischemic Attack

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Volume 14, Issue 6, Pages (June 2017)

Cardiovascular Disease and CKD: Core Curriculum 2010

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines Laurent Macle, MD,

CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation

Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without.

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

Truman J. Milling, MD, Alex C. Spyropoulos, MD

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

Counterpoint: Should All ICU Patients Receive Continuous Sedation? No

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Atul Verma, MD, John A. Cairns, MD, L.

Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation Kareem Bedeir, MBChB, MS, David R. Holmes, MD,

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

Imaging for the Management of Community-Acquired Pneumonia

Optimizing Atrial Fibrillation Management

Possible Role of Statins in COPD-Related Pulmonary Hypertension

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Jason G. Andrade, MD, Atul Verma, MD,

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter

Bedside Calibration Of Pulmonary Artery Catheters

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

Björn Redfors et al. JACEP 2017;j.jacep

Mc Grath Gregory , MD, Das-Gupta Mike , MD, Clarke Geoffrey , MD CHEST

Volume 42, Issue 2, Pages (August 1962)

Calcification of the Coronary Artery

Volume 72, Issue 5, Pages (November 1977)

Erratum Canadian Journal of Cardiology

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management Anne M. Gillis, MD, FRCPC, Atul Verma, MD, FRCPC, Mario.

William E. Evans, M.D., James P. Hayes, M.S.

Figure 8. Stroke prevention strategy in patients with AF

New Members of the Editorial Board

Volume 14, Issue 6, Pages (June 2017)

Presentation transcript:

The 2010 European Society of Cardiology Guidelines on the Management of Atrial Fibrillation Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD CHEST Volume 139, Issue 4, Pages 738-741 (April 2011) DOI: 10.1378/chest.10-2763 Copyright © 2011 The American College of Chest Physicians Terms and Conditions

Figure 1 Algorithm summarizing the approach to thromboprophylaxis in the 2010 European Society of Cardiology guidelines for management of patients with AF. CHADS2 = congestive heart failure, hypertension, age, diabetes, prior stroke or transient ischemic attack; OAC = oral anticoagulation; TIA = transient ischemic attack. (Republished with permission from the European Heart Journal1). CHEST 2011 139, 738-741DOI: (10.1378/chest.10-2763) Copyright © 2011 The American College of Chest Physicians Terms and Conditions